7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.

      The Lancet Infectious Diseases
      AIDS-Related Opportunistic Infections, complications, drug therapy, epidemiology, prevention & control, Anti-HIV Agents, therapeutic use, Disease Outbreaks, Global Health, HIV Infections, Health Services Accessibility, Humans, Prevalence, Treatment Outcome, Tuberculosis, Tuberculosis, Multidrug-Resistant

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tuberculosis is the oldest of the world's current pandemics and causes 8.9 million new cases and 1.7 million deaths annually. The disease is among the most common causes of morbidity and mortality in people living with HIV. However, tuberculosis is more than just part of the global HIV problem; well-resourced tuberculosis programmes are an important part of the solution to scaling-up towards universal access to comprehensive HIV prevention, diagnosis, care, and support. This article reviews the impact of the interactions between tuberculosis and HIV in resource-limited settings; outlines the recommended programmatic and clinical responses to the dual epidemics, highlighting the role of tuberculosis/HIV collaboration in increasing access to prevention, diagnostic, and treatment services; and reviews progress in the global response to the epidemic of HIV-related tuberculosis.

          Related collections

          Author and article information

          Comments

          Comment on this article